AKYA
NASDAQAkoya BioSciences Inc.
Price$1.30+0.13 (+11.11%)
2025-06-042025-07-07
Latest news
25 items- SECSEC Form 15-12G filed by Akoya BioSciences Inc.15-12G - Akoya Biosciences, Inc. (0001711933) (Filer)
- SECSEC Form EFFECT filed by Akoya BioSciences Inc.EFFECT - Akoya Biosciences, Inc. (0001711933) (Filer)
- INSIDERDirector Mendel Scott disposed of 28,500 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- INSIDERChief Business Officer Ramachandran Niro Ph.D acquired 62,566 shares, covered exercise/tax liability with 42,148 shares and disposed of 282,555 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- INSIDERPresident and CEO Mckelligon Brian disposed of 947,688 shares, acquired 724,428 shares and covered exercise/tax liability with 196,866 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- INSIDERChief Legal Officer Kamocsay Jennifer disposed of 179,272 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- INSIDERCFO Ek John Frederick disposed of 268,202 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- INSIDERChief Clinical Officer Bamford Pascal disposed of 205,738 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- INSIDERDirector Winkler Matthew disposed of 984,513 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- INSIDERSEC Form 4 filed by Director Shepler Robert G4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- INSIDERSEC Form 4 filed by Director Schnettler Thomas P4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- INSIDERDirector Raffin Thomas A. disposed of 17,909,839 shares (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- INSIDERDirector Lai Goldman Myla disposed of 20,000 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SECSEC Form S-8 POS filed by Akoya BioSciences Inc.S-8 POS - Akoya Biosciences, Inc. (0001711933) (Filer)
- SECSEC Form S-8 POS filed by Akoya BioSciences Inc.S-8 POS - Akoya Biosciences, Inc. (0001711933) (Filer)
- SECSEC Form S-8 POS filed by Akoya BioSciences Inc.S-8 POS - Akoya Biosciences, Inc. (0001711933) (Filer)
- SECSEC Form S-8 POS filed by Akoya BioSciences Inc.S-8 POS - Akoya Biosciences, Inc. (0001711933) (Filer)
- SECSEC Form S-8 POS filed by Akoya BioSciences Inc.S-8 POS - Akoya Biosciences, Inc. (0001711933) (Filer)
- SECSEC Form POS AM filed by Akoya BioSciences Inc.POS AM - Akoya Biosciences, Inc. (0001711933) (Filer)
- SECSEC Form 25-NSE filed by Akoya BioSciences Inc.25-NSE - Akoya Biosciences, Inc. (0001711933) (Subject)
- SECAkoya BioSciences Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits8-K - Akoya Biosciences, Inc. (0001711933) (Filer)
- SECAkoya BioSciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Akoya Biosciences, Inc. (0001711933) (Filer)
- SECSEC Form DEFM14A filed by Akoya BioSciences Inc.DEFM14A - Akoya Biosciences, Inc. (0001711933) (Filer)
- SECSEC Form 425 filed by Akoya BioSciences Inc.425 - Akoya Biosciences, Inc. (0001711933) (Subject)
- INSIDERChief Clinical Officer Bamford Pascal covered exercise/tax liability with 670 shares, decreasing direct ownership by 0.32% to 205,738 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
AKYA FAQ
7 questionsWhat does Akoya BioSciences Inc. do?
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in...Where does AKYA stock trade?
Akoya BioSciences Inc. (AKYA) is listed on NASDAQ.What sector and industry is AKYA in?
Akoya BioSciences Inc. operates in the Industrials sector, Biotechnology: Laboratory Analytical Instruments industry.When did Akoya BioSciences Inc. go public?
Akoya BioSciences Inc. (AKYA) completed its IPO in 2021.What are analysts saying about AKYA?
Akoya BioSciences Inc. has had 8 recent analyst actions on file. The most recent action was from Craig Hallum: Hold with a $500.00 price target on 2024-11-15. Recent price targets range from $500.00 to $1800.00.What companies are similar to AKYA?
Notable peers in the same industry include A (Agilent Technologies Inc.), WAT (Waters Corporation), MTD (Mettler-Toledo International Inc.), PKI (PerkinElmer Inc.), RVTY (Revvity Inc.). Compare AKYA side-by-side with any of them on Quantisnow.How can I track AKYA on Quantisnow?
Quantisnow aggregates Akoya BioSciences Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AKYA to receive live email and push alerts on every new disclosure.